Lamond A. David's most recent trade in Quince Therapeutics Inc was a trade of 27,000 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 27,000 | 27,000 | - | - | Director Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 47,587 | 47,587 | - | - | Director Stock Option (right to buy) | |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 27,000 | 27,000 | - | - | Employee Stock Option (right to buy) | |
| Quince Therapeutics Inc | David Lamond A. | Director | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 12 Dec 2023 | 22,627 | 2,347,545 (7%) | 0% | 1.0 | 23,532 | Common Stock |
| Quince Therapeutics Inc | A. David Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 12 Dec 2023 | 22,627 | 2,324,918 (7%) | 0% | 1 | 22,627 | Common Stock |
| Quince Therapeutics Inc | A. David Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 12 Dec 2023 | 22,327 | 2,302,291 (7%) | 0% | 1.0 | 22,774 | Common Stock |
| Quince Therapeutics Inc | A. Lamond David | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 12 Dec 2023 | 300 | 2,279,964 (7%) | 0% | 1 | 300 | Common Stock |
| Quince Therapeutics Inc | David Lamond A. | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 05 Dec 2023 | 19,123 | 2,260,541 (7%) | 0% | 1.0 | 19,505 | Common Stock |
| Quince Therapeutics Inc | Lamond A. David | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 05 Dec 2023 | 19,123 | 2,279,664 (7%) | 0% | 1.0 | 19,314 | Common Stock |
| Quince Therapeutics Inc | A. Lamond David | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 05 Dec 2023 | 19,123 | 2,241,418 (7%) | 0% | 1.0 | 19,314 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 30 Aug 2023 | 41,026 | 2,179,161 (7%) | 0% | 1.3 | 54,154 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 30 Aug 2023 | 41,026 | 2,138,135 (7%) | 0% | 1.3 | 53,744 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 15 Aug 2023 | 117,348 | 2,072,343 (7%) | 0% | 1.3 | 151,379 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 15 Aug 2023 | 107,886 | 1,954,995 (6%) | 0% | 1.3 | 142,410 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 15 Aug 2023 | 24,766 | 2,097,109 (7%) | 0% | 1.3 | 31,948 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Applied Molecular Transpor... | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Applied Molecular Transpor... | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 3.26 per share. | 20 May 2022 | 33,500 | 1,077,519 | - | 3.3 | 109,210 | Common Stock |
| Applied Molecular Transpor... | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 3.08 per share. | 20 May 2022 | 33,000 | 1,044,019 | - | 3.1 | 101,640 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 200,002 | 1,734,722 (5%) | 0% | - | Common Stock | |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 11,029 | 11,029 | - | - | Stock Option (right to buy) | |
| Applied Molecular Transpor... | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 15,175 | 15,175 | - | - | Stock Option (Right to Buy) | |
| Applied Molecular Transpor... | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 42.00 per share. | 06 Apr 2021 | 25,000 | 1,011,019 | - | 42 | 1,050,000 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 33.77 per share. | 24 Mar 2021 | 50,000 | 1,847,109 (6%) | 0% | 33.8 | 1,688,500 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2021 | 1,534,720 | 1,534,720 (5%) | 5% | 0 | Common Stock | |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 34.28 per share. | 04 Mar 2021 | 16,621 | 1,763,730 (6%) | 0% | 34.3 | 569,768 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 36.34 per share. | 04 Mar 2021 | 15,969 | 1,793,009 (6%) | 0% | 36.3 | 580,313 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 35.00 per share. | 04 Mar 2021 | 13,310 | 1,777,040 (6%) | 0% | 35 | 465,850 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 36.86 per share. | 04 Mar 2021 | 4,100 | 1,797,109 (6%) | 0% | 36.9 | 151,126 | Common Stock |